S

Sofwave Medical Ltd
TASE:SOFW

Watchlist Manager
Sofwave Medical Ltd
TASE:SOFW
Watchlist
Price: 4 321 ILS 3.5%
Market Cap: ₪1.5B

Sofwave Medical Ltd
Capital Expenditures

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sofwave Medical Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
S
Sofwave Medical Ltd
TASE:SOFW
Capital Expenditures
-$534k
CAGR 3-Years
-6%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Capital Expenditures
-$2.8m
CAGR 3-Years
51%
CAGR 5-Years
-84%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Capital Expenditures
-$3.9m
CAGR 3-Years
N/A
CAGR 5-Years
-6%
CAGR 10-Years
-6%
Inmode Ltd
NASDAQ:INMD
Capital Expenditures
-$972k
CAGR 3-Years
15%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Capital Expenditures
-$18.7m
CAGR 3-Years
-54%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
A
Alpha Tau Medical Ltd
NASDAQ:DRTS
Capital Expenditures
-$6.1m
CAGR 3-Years
-89%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
No Stocks Found

Sofwave Medical Ltd
Glance View

Market Cap
1.5B ILS
Industry
Health Care

Sofwave Medical Ltd. engages in development, production, marketing, maintenance, and distribution of medical technology for firming and rejuvenating facial and neck skin. The firm operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The firm has subsidiary in United States -Sofwave Medical Inc.

SOFW Intrinsic Value
1 476.21 ILS
Overvaluation 66%
Intrinsic Value
Price ₪4 321
S

See Also

What is Sofwave Medical Ltd's Capital Expenditures?
Capital Expenditures
-534k USD

Based on the financial report for Dec 31, 2025, Sofwave Medical Ltd's Capital Expenditures amounts to -534k USD.

What is Sofwave Medical Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-15%

Over the last year, the Capital Expenditures growth was -93%. The average annual Capital Expenditures growth rates for Sofwave Medical Ltd have been -6% over the past three years , -15% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett